← k3vl4r
Log inGet started →

INCY (Incyte) Price Forecast

AI-generated price forecast for Incyte (INCY) across 1-hour, 4-hour, daily and weekly horizons — updated continuously, with a public accuracy track record.

The desk streams live daily· see the schedule →

As of October 2026: K3vl4r's AI model currently reads INCY as 2/2 bearish · strong across its horizons (0 of 2 timeframes pointing up), with a last price of 116.50. See our public, auditable track record →

📈 Daily Top Picks beating the S&P 500 since launch→✓ Public, verifiable track record Live system status💎 Get the full AI report · pay with XRP

Last price

116.50

AI outlook

2/2 bearish · STRONG

Timeframes up

0 / 2

Share𝕏PostTelegram

INCY forecast by horizon

HorizonDirectionProjected move (end of horizon)Bullish prob.
1-hour———
4-hour———
Daily~3 months out▼ Down-30.02%0%
Weekly~1.8 years out▼ Down-32.66%—

Latest INCY news

From the market-news feed the forecasts are read against.

  • Q2 Earnings Roundup: Incyte (NASDAQ:INCY) And The Rest Of The Biotechnology Segment · Yahoo · Oct 1
  • Wells Fargo Maintains Equal-Weight on Incyte, Raises Price Target to $128 · Benzinga · Oct 1
  • INCY or TECH: Which Is the Better Value Stock Right Now? · Yahoo · Sep 30
  • Incyte (NASDAQ:INCY) Combines High Growth Momentum With a Breakout Setup · ChartMill · Sep 30
  • MIRM Secures FDA Nod for an Ultra-Rare Bone Disorder Therapy · Yahoo · Sep 28

🔒

See the full INCY forecast

Interactive forecast chart, price targets, and Monte-Carlo confidence bands — plus the daily AI Top Picks book. Free to start, no card required.

Create a free account →

Already have one? Log in

INCY forecast — frequently asked

Will INCY go up?

K3vl4r's AI model currently reads INCY as 2/2 bearish · STRONG — 0 of 2 forecast horizons point up, so the overall read is leaning to the downside. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What is the INCY price prediction for 2026?

K3vl4r's model projects INCY toward $117.87 over the next ~3 months, a -0.3% move from $118.22. Projections update continuously as new data arrives and are inherently uncertain. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

What price could INCY reach?

Over its longest horizon (~~1.8 years), the model's projected target for INCY is $120.95 (-0.3% vs $121.35). Confidence decreases the further out the horizon, so treat longer-range targets as one scenario, not a guarantee. This is a model-generated forecast for information only — not investment advice, and forecasts may be inaccurate.

Part of Biotech & Pharma forecasts — browse the full sector.

More AI forecasts

NBIXVRTXTMDXPRTADNASUPNNTLAIOVAIRWDUTHRAGIOMRNABNTXBEAM

Will INCY reach…?

Will INCY reach $200.00?Will INCY reach $250.00?Will INCY reach $500.00?

Or see the full INCY price prediction (2027–2040), or the forecast for today, tomorrow and this week.

Compare INCY

INCY vs NBIXINCY vs VRTXINCY vs TMDXINCY vs PRTAINCY vs DNAINCY vs SUPN

Curious how this is generated? Read how K3vl4r forecasts — the model, the confidence bands, and what we deliberately do not claim.

K3vl4r publishes a public, auditable track record of its Daily Top Picks — see the live results.

Forecasts are model-generated estimates for informational purposes only and are not financial advice. Markets are risky; past accuracy does not guarantee future results. See our Risk Disclosure.

StreamWatch on Kick·Watch on YouTube
k3vl4rTop PicksTrack recordChart indicatorsToday's outlookStream scheduleBiggest moversMarket heatmapForecasts by sectorAI reportsMarket videosCompareMethodologyBest AI toolsAboutFAQ◈ KVLHow KVL worksTokenomicsPricingX (Twitter)YouTube — daily showsTikTokTwitch — live forecastingDiscord community

Join the community on Discord and catch the desk stream live on Kick or YouTube. Create a free account →

Forecasts are AI-generated; written analysis is AI-assisted and human-reviewed. Informational only, not financial advice. See Terms, Risk Disclosure, Privacy · Methodology · Status.